One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

How we dress, where we go, what we search for and what we buy in 2025 says it all. And while most trends are living on borrowed time of days or weeks — maybe months if they’re lucky — a select few ...

With many biotechs and pharmas needing to fill impending revenue holes coming later in the decade, M&A is posed to pick up, but not until government and regulatory uncertainty settles down. Dealmaking ...

Healthcare Bankruptcies Down, Still Second Highest on Record - Senior care, pharmaceutical companies, and physician practices ...

A pair of Chinese manufacturers whose active pharmaceutical ingredients (API) were previously shipped to the U.S. | The FDA ...

In California, technology, retail and pharmaceutical companies appear to be taking on the bulk of the layoffs as employers ...

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund.

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.